On Tuesday, Jan. 10, Global Healthcare will become Reuters Health Rounds, a newsletter curated by Nancy Lapid, editor in charge of Reuters Health. Reuters Health Rounds will be sent on Tuesdays and Thursdays.
Trader Joe's was sued on Wednesday by a consumer who accused the grocery chain of misleading and endangering shoppers by selling dark chocolate that contains harmful levels of lead and cadmium.
European Union government officials recommended on Wednesday that passengers flying from China to the EU should have a negative COVID-19 test before they board, as Beijing plans to ease travel restrictions despite a wave of new COVID infections.
Data from China shows that no new coronavirus variant has been found there, but also that the country under-represents how many people have died in a rapidly spreading COVID-19 outbreak, World Health Organization (WHO) officials said on Wednesday.
Greece announced on Wednesday additional measures to deal with certain drug shortages, a problem it said was global and attributed to an increase in seasonal virus infections, supply chain issues, the energy crisis and reduced exports from Asia.
Sponsored by GE HealthCare: The Next era of GE HealthCare
As a stand-alone company, GE HealthCare is a leader in precision care, infusing innovation with patient-focused technologies to enable better care for patients and providers.
China's COVID-19 data is not giving an accurate picture of the situation there and underrepresents the number of hospitalisations and deaths from the disease, a senior official at the World Health Organization said on Wednesday.
China's recent COVID-19 outbreak is predominantly led by the Omicron subvariants BA.5.2 and BF.7, which together account for 97.5% of all local infections, the World Health Organization said on Wednesday.
Geron Corp said on Wednesday its experimental drug helped more patients with a difficult-to-treat blood cancer achieve independence from routine transfusions in a late-stage trial, sending shares of the drug developer nearly 50% higher.
Moderna Inc on Wednesday agreed to buy Japan-based OriCiro Genomics for $85 million to boost the U.S. drugmaker's messenger RNA (mRNA) manufacturing capabilities.
China's cabinet said it will step up medicine distribution and meet the demand from medical institutions, nursing homes and rural areas, state media reported on Wednesday, amid a surge in COVID-19 infections.
